Efficacy of Pregabalin and Venlafaxine-XR in generalized anxiety disorder: Results of a double-blind, placebo-controlled 8-week trial

被引：0
|
作者：
Murphy, T. K. [1 ]
Nivoli, G. [2 ]
Petralia, A. [3 ]
Mandel, F. [1 ]
机构：
[1] Pfizer Inc, New York, NY USA
[2] Univ Sassari, I-07100 Sassari, Italy
[3] Univ Catania, Catania, Italy
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
下载
收藏
页码：S215 / S215
页数：1
相关论文
共 50 条
  • [1] Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial
    Kasper, Siegfried
    Herman, Barry
    Nivoli, Giancarlo
    Van Ameringen, Michael
    Petralia, Antonino
    Mandel, Francine S.
    Baldinetti, Francesca
    Bandelow, Borwin
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2009, 24 (02) : 87 - 96
  • [2] Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial
    Herman, B. K.
    Nivoli, G.
    Petralia, A.
    Mandel, F.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 277 - 277
  • [3] Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: Results of a double-blind, placebo-controlled 8-week trial (A0081012)
    Murphy, T. K.
    Nivoli, G.
    Petralia, A.
    Mandel, F.
    Leon, T.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 333 - 334
  • [4] A randomized, double-blind, 8-week comparison of venlafaxine XR and placebo in out-patients with Generalized Anxiety Disorder
    Kogeorgos, J
    Nimatoudis, I
    Zissis, N
    Tsilikas, S
    Charalambopoulos, I
    Zittis, M
    Moulatsiotis, T
    Vidalis, A
    Kaprinis, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S304 - S304
  • [5] Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: A 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine
    Montgomery, Stuart A.
    Tobias, Kathy
    Zornberg, Gwen L.
    Kasper, Siegfried
    Pande, Atul C.
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (05) : 771 - 782
  • [6] Pregabalin for treatment of generalized anxiety disorder - A 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam
    Rickels, K
    Pollack, MH
    Feltner, DE
    Lydiard, RB
    Zimbroff, DL
    Bielski, RJ
    Tobias, K
    Brock, JD
    Zornberg, GL
    Pande, AC
    ARCHIVES OF GENERAL PSYCHIATRY, 2005, 62 (09) : 1022 - 1030
  • [7] Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial
    Bidzan, Leszek
    Mahableshwarkar, Atul R.
    Jacobsen, Paula
    Yan, Mingjin
    Sheehan, David V.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 (12) : 847 - 857
  • [8] Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study
    Greist, John H.
    Liu-Dumaw, Maria
    Schweizer, Edward
    Feltner, Douglas
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (05) : 243 - 251
  • [9] Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study
    Feltner, Douglas E.
    Liu-Dumaw, Maria
    Schweizer, Edward
    Bielski, Robert
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2011, 26 (04) : 213 - 220
  • [10] Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR
    Hewett, K.
    Chrzanowski, W.
    Schmitz, M.
    Savela, A.
    Milanova, V.
    Gee, M.
    Krishen, A.
    Millen, L.
    Leary, M. O.
    Modell, J.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (05) : 531 - 538
12345